175 related articles for article (PubMed ID: 22978304)
1. Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.
El-Fakharany EM; Abedelbaky N; Haroun BM; Sánchez L; Redwan NA; Redwan EM
Virol J; 2012 Sep; 9():201. PubMed ID: 22978304
[TBL] [Abstract][Full Text] [Related]
2. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.
Redwan EM; El-Fakharany EM; Uversky VN; Linjawi MH
BMC Complement Altern Med; 2014 Jul; 14():219. PubMed ID: 24993815
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.
El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM
Virol J; 2013 Jun; 10():199. PubMed ID: 23782993
[TBL] [Abstract][Full Text] [Related]
4. Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and hela cell lines.
Almahdy O; El-Fakharany EM; El-Dabaa E; Ng TB; Redwan EM
Hepat Mon; 2011 Sep; 11(9):724-30. PubMed ID: 22235215
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
Liao Y; El-Fakkarany E; Lönnerdal B; Redwan EM
J Med Microbiol; 2012 Mar; 61(Pt 3):375-383. PubMed ID: 22052996
[TBL] [Abstract][Full Text] [Related]
6. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
Redwan el-RM; Tabll A
J Immunoassay Immunochem; 2007; 28(3):267-77. PubMed ID: 17613672
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.
Dominguez-Molina B; Machmach K; Perales C; Tarancon-Diez L; Gallego I; Sheldon JL; Leal M; Domingo E; Ruiz-Mateos E
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232187
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins.
Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM
Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141
[TBL] [Abstract][Full Text] [Related]
9. Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells.
Liao W; Liu X; Yang Q; Liu H; Liang B; Jiang J; Huang J; Ning C; Zang N; Zhou B; Liao Y; Chen J; Tian L; Ho W; Abdullah AS; Kong L; Liang H; Chen H; Ye L
Antiviral Res; 2020 Feb; 174():104704. PubMed ID: 31917237
[TBL] [Abstract][Full Text] [Related]
10. Humanized-VHH transbodies that inhibit HCV protease and replication.
Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
[TBL] [Abstract][Full Text] [Related]
11. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
[TBL] [Abstract][Full Text] [Related]
12. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.
Yang D; Zuo C; Wang X; Meng X; Xue B; Liu N; Yu R; Qin Y; Gao Y; Wang Q; Hu J; Wang L; Zhou Z; Liu B; Tan D; Guan Y; Zhu H
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1264-73. PubMed ID: 24616513
[TBL] [Abstract][Full Text] [Related]
13. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
[TBL] [Abstract][Full Text] [Related]
14. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
[TBL] [Abstract][Full Text] [Related]
15. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
16. The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.
Kwon YC; Kang JI; Hwang SB; Ahn BY
FEBS Lett; 2013 Jan; 587(2):156-64. PubMed ID: 23196181
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.
Zhang X; Daucher M; Armistead D; Russell R; Kottilil S
PLoS One; 2013; 8(2):e55733. PubMed ID: 23418453
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA let-7b inhibits hepatitis C virus and induces apoptosis in human hepatoma cells.
Jamalidoust M; Shafaati M; Kalani M; Zare M; Ziyeayan M
Mol Biol Rep; 2022 Feb; 49(2):1273-1280. PubMed ID: 34807376
[TBL] [Abstract][Full Text] [Related]
20. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
Cai Z; Zhang C; Chang KS; Jiang J; Ahn BC; Wakita T; Liang TJ; Luo G
J Virol; 2005 Nov; 79(22):13963-73. PubMed ID: 16254332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
